Search
Search Constraints
You searched for: Author/Creator Pavitra, Eluri Issue Volume 69(2021)Limit your search
- Pavitra, Eluri [remove] 3
- 616.994 3
- Cancer -- Periodicals 3
- Cancer -- Périodiques 3
- Electronic journals 3
- Neoplasms -- Periodicals 3
- Review Literature 3
- ABUS automated breast US -- Ag2S-NP silver sulfide NPs -- AION all-in-one NP -- BC breast cancer -- BTNPs biocompatible piezoelectric barium titanate NPs -- CAs contrast agents -- CC cervical cancer -- CN carbon nanotubes -- CP carboplatin -- CT computed tomography -- DCE dynamic contrast-enhanced -- DISC ductal carcinoma in situ -- EGCG epigallocatechin-gallate -- FDA food and drug administration -- Fe3O4 ferrosoferric oxide -- Gd gadolinium -- GRPR gastrin releasing peptide receptors -- HER2 human epidermal growth factor receptor 2 -- IO-NP iron oxide NPs -- LCP lipid/calcium/phosphate -- MIS minimally invasive surgery -- MRI magnetic resonance imaging -- NAUT NP-assisted ultrasound therapy -- Nbs nanobodies -- NCs nanocarriers -- NIR near infrared -- NP nanoparticle -- NVs nanovehicles -- OC ovarian cancer -- PA photoacoustic -- PCI photochemical internalization -- PET positron emission tomography -- PLA polymeric polylactic acid -- PTX paclitaxel -- QDs quantum dots -- SMA poly(styrene)-co-maleic acid -- SPECT single photon emission computed tomography -- SPION superparamagnetic iron oxide nanoparticles -- SQUID superconducting quantum interference device -- SWBUS screening whole breast ultra sound -- SWBUS screening whole breast US -- Ta4C3 tantalum carbide -- TSNs thermosponge NPs -- US ultrasonography 1
- AuNPs gold nanoparticles -- CEA carcino embryonic antigen -- CLM colorectal liver metastasis -- DOX doxorubicin -- DPYD dihydropyrimidine dehydrogenase -- EPR enhanced permeability and retention -- hENT1 human equilibrative nucleoside transporter 1 -- HPβCD hydroxypropyl β-cyclodextrin -- ICD immunogenic cell death -- IDO indoleamine 2, 3-dioxygenase -- ITM immunosuppressive microenvironment of tumor -- isoCA-4 isocombretastatin A-4 -- LbL layer-by-layer carrier system -- LCL long circulating liposome -- LDH layered double hydroxide -- MCM mobil composition of matter -- MDR multidrug resistance -- MDT magnetic drug targeting -- MSN mesoporous silica nanoparticle -- MUC mucin -- NPs nanoparticles -- PCL poly capro lactone -- PDL programmed cell death ligand -- PDT photodynamic therapy -- pDNA plasmid DNA -- PEG polyethylene glycol -- PLGA poly lactic-co-glycolic acid -- PNA peanut agglutinin -- PTT photothermal therapy -- QD quantum dots -- SERS surface enhanced Raman spectroscopy -- SLN solid lipid nanoparticle -- SQ squalene -- VEGF vascular endothelial growth factor 1
- CNTs carbon nanotubes -- CuS copper sulfide -- EPR enhanced permeability and retention -- GALA glutamic acid-alanine-leucine-alanine -- GSH glutathionine -- AuNPs gold nanoparticles -- MRI magnetic resonance imagining -- MSNPs mesoporous silica nanoparticles -- NPs nanoparticles -- NIR near infrared -- PLA2 phospholipases A2 -- PA photoacoustic -- PHBV poly (3-hydroxybutyrate-co-3-hydroxyvalerate) -- PLGA poly(lactic-co-glycolic acid) -- PAMAM polyamidoamine -- PEG polyethylene glycol -- PM polymeric micelles -- QDs quantum dots -- ROS reactive oxygen species -- AgNPs silver nanoparticles -- siRNA small-interfering RNAs -- SPIONs superparamagnetic iron oxide nanoparticles -- TAM tumor associated macrophage 1
- Colorectal cancer -- Chemotherapy -- Nanoparticle -- Imaging -- Drug delivery 1